A novel RP-HPLC stability-indicating method for simultaneous estimation of Niraparib and Abiraterone in synthetic mixtures and combined tablet formulations

Abstract Niraparib and Abiraterone in a combined dosage form offer a fortunate regimen for treating cancers, mainly those resistant to conventional therapies cast in cancer treatment. The present study intends to develop a novel RP-HPLC method for simultaneously estimating Niraparib and Abiraterone...

Descripción completa

Detalles Bibliográficos

Autores principales:	Krishnaphanisri Ponnekanti, Ramreddy Godela, Divya Reddy Solipeta, K. Sujatha, Durga Prasad Beda
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Springer 2025-05-01
Colección:	Discover Applied Sciences
Materias:	Niraparib Abiraterone Stability-indicating RP-HPLC Isocratic elution Forced degradation
Acceso en línea:	https://doi.org/10.1007/s42452-025-06930-5
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!